Abstract
The objectives of this study are to compare the results of newer performance-based functional assessments in the study of HIV-associated neurocognitive disorders (HAND) and to correlate these functional assessments with specific levels of severity of HAND. One hundred fourteen HIV+ subjects in an existing cohort were evaluated with a medical history, neurological exam, neuropsychological test battery as well as subjective and novel objective measures of functional abilities. Self-reported measures of functional performance included the Karnofsky Performance Scale, a questionnaire for instrumental activities of daily living, and a questionnaire for physical quality of life measures. The newer objective functional performance assessments included the Columbia Medication Management and the San Diego Finances tests. These newer performance-based measures of function were assessed for their ability to predict level of HAND. The two objective measures of functional performance, The Columbia Medication Management Scale and the San Diego Finances Test, were both associated with levels of severity of HAND. The Karnofsky Performance Scale and the questionnaires for role and physical quality of life were subjective measures that were also associated with specific levels of HAND. Newer measures of functional performance can be used to objectively evaluate functional impairment in HAND and validate different levels of HAND.
Similar content being viewed by others
References
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799
Benedict RH, Mezhir JJ, Walsh K, Hewitt RG (2000) Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol 15:535–544
Fahn S, Marsden C, Caine D (1987) Recent developments in Parkinson’s disease. Macmillan Healthcare Information, Florham Park
Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R (2002) Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns 46:93–108
Fuh JL, Wang SJ (2006) Assessing quality of life in Taiwanese patients with Alzheimer’s disease. Int J Geriatr Psychiatry 21:103–107
Gandhi NS, Moxley CJ, Vornbrock Roosa H, Skolasky RL, Selnes OA, McArthur J, Sacktor N (2010) Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Therapy 4:373–379
Graham DP, Kunik ME, Doody R, Snow AL (2005) Self-reported awareness of performance in dementia. Brain Res Cogn Brain Res 25:144–152
Gross R (2007) Predicting and monitoring antiretroviral adherence. LDI Issue Brief 13:1–4
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317–331
Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, Goetz MB, Stefaniak M (2002) Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 59:1944–1950
Karnofsky D, Abelman W, Craver L, Burchenal J (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
McArthur JC, McDermott M, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein LG (2004) Attenuated CNS infection in advanced HIV/AIDS with highly active antireteroviral therapy. Arch Neurol 61:1687–1696
Mohamed MA, Barker PB, Skolasky RL, Moxley RT, Pomper MG, Sacktor NC (2010) Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging 28(9):1251–1257
Munakata J, Benner JS, Becker S, Dezii CM, Hazard EH, Tierce JC (2006) Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with human immunodeficiency virus. Med Care 44:893–899
Ready RE, Ott BR (2007) Integrating patient and informant reports on the cornell-brown quality-of-life scale. Am J Alzheimers Dis Other Demen 22:528–534
Ready RE, Ott BR, Grace J (2004a) Validity of informant reports about AD and MCI patients’ memory. Alzheimer Dis Assoc Disord 18:11–16
Ready RE, Ott BR, Grace J (2004b) Patient versus informant perspectives of quality of life in mild cognitive impairment and alzheimer’s disease. Int J Geriatr Psychiatry 19:256–265
Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2):115–121
Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136–142
Saxton J, Morrow LA, Baumann S, Zuccolotto A, Schneider W, Offerman J, Dekosky ST (2005) The computer-based assessment of mild cognitive impairment (CAMCI). Thirty-Third Annual International Neuropsychological Society Conference 33
Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, Palumbo D, Selnes O, Stern Y, Epstein L, Albert S (2001) Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology 56:415–418
Snow AL, Graham DP, Molinari VA, Orengo CA, Doody RS, Norris MP, Kunik ME (2005) Factors affecting deficit awareness in persons with dementia. Dement Geriatr Cogn Disord 20:133–139
Van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG (1999) The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc 5:534–539
Vogel A, Mortensen EL, Hasselbalch SG, Andersen BB, Waldemar G (2006) Patient versus informant reported quality of life in the earliest phases of Alzheimer’s disease. Int J Geriatr Psychiatry 21:1132–1138
Disclosure
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Johns Hopkins NIMH Center for Novel Therapeutics of HIV Associated Cognitive Disorders (MH 075673), (MH71150), and (NS 049465)
Rights and permissions
About this article
Cite this article
Gandhi, N.S., Skolasky, R.L., Peters, K.B. et al. A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. J. Neurovirol. 17, 159–165 (2011). https://doi.org/10.1007/s13365-011-0023-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-011-0023-8